Almirall Hermal GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 2004, the company has established itself as a leader in dermatology and other therapeutic areas, focusing on innovative treatments that address unmet medical needs. Almirall is renowned for its core products, which include prescription medications and dermatological solutions that stand out for their efficacy and safety profiles. The company’s commitment to research and development has led to significant milestones, enhancing its reputation in the competitive pharmaceutical landscape. With a strong market position, Almirall Hermal GmbH continues to achieve notable successes, driven by its dedication to improving patient outcomes and advancing healthcare solutions.
How does Almirall Hermal GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Almirall Hermal GmbH's score of 88 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Almirall Hermal GmbH, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. The company is a current subsidiary of Almirall, S.A., which may influence its climate commitments and reporting practices. While no direct emissions data is available, Almirall Hermal GmbH's climate initiatives and targets are inherited from its parent company, Almirall, S.A. This includes participation in various sustainability frameworks, such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements have not been disclosed for Almirall Hermal GmbH. As a subsidiary, Almirall Hermal GmbH aligns with the broader corporate sustainability goals set by Almirall, S.A., which may include commitments to reduce emissions across Scope 1, 2, and 3 categories. The absence of specific data highlights the need for further transparency in emissions reporting and climate action commitments within the organisation.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 6,864,000 | 000,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 2 | 6,305,000 | - | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 3 | 62,838,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 
Almirall Hermal GmbH's Scope 3 emissions, which decreased by 9% last year and increased by approximately 126% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 88% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Almirall Hermal GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.